Bioreachable chiral dopants for liquid crystal applications

US11814563B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11814563-B2
Application numberUS-201917299777-A
CountryUS
Kind codeB2
Filing dateDec 6, 2019
Priority dateDec 7, 2018
Publication dateNov 14, 2023
Grant dateNov 14, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The disclosure discusses chiral dopants for liquid-crystalline materials. Chiral dopants can be bioreachable compounds, i.e. compounds produced from microbes through fermentation. Chiral dopants can also include bioreachable materials that are further modified by chemical synthetic steps. Chiral dopants as discussed herein can include biomolecules such as glycyrrhetinic acid (1), S-naringenin (2), shikimic acid (3), alpha-phellandrene (4), betulin (5), malic acid (6), valencene (7), or nootkatone (8), and any stereoisomers or chemically modified derivatives thereof. The disclosure further shows optical properties of such compounds in a liquid-crystalline material.

First claim

Opening claim text (preview).

What is claimed is: 1. A liquid-crystalline material comprising at least one chiral dopant selected from the group consisting of the structures wherein R 1 , R 2 , R 3 , and R 4 are each independently hydrogen, an aliphatic moiety, an aryl moiety, an arylalkylene moiety, an alkyl arylene moiety, an alkanoyl moiety, an arylalkanoyl moiety, or any halogenated derivative of the foregoing moieties, and wherein Z is selected from C(H)R 5 , —CR 5 ═CR 5 —, O, S, or NRs, wherein R 5 is independently hydrogen, an aliphatic moiety, an aryl moiety, an arylalkylene moiety, an alkyl arylene moiety, an alkanoyl moiety, an arylalkanoyl moiety, or any halogenated derivative of the foregoing moieties, and a nematic or a nematogenic substance. 2. The liquid-crystalline material according to claim 1 , wherein the at least one chiral dopant is present in an amount of at least 0.001 wt %, based on the weight of the liquid-crystalline material. 3. The liquid-crystalline material according to claim 1 , wherein the at least one chiral dopant is present in an amount of not greater than 20 wt %, based on the weight of the liquid-crystalline material. 4. The liquid-crystalline material according to claim 1 , further comprising at least one polymerizable mesogenic compound having at least one polymerizable functional group. 5. The liquid-crystalline material according to claim 4 , wherein the at least one polymerizable functional group includes an epoxy group, a vinyl group, an allyl group, an acrylate, a methacrylate, an isoprene group, an alpha-amino carboxylate, or any combination thereof. 6. The liquid-crystalline material according to claim 1 , wherein the nematic or the nematogenic substance is selected from azoxybenzenes, benzylideneanilines, biphenyls, terphenyls, phenyl benzoates, cyclohexyl benzoates, phenyl esters of cyclohexanecarboxylic acid, cyclohexyl esters of cyclohexanecarboxylic acid, phenyl esters of cyclohexylbenzoic acid, cyclohexyl esters of cyclohexylbenzoic acid, phenyl esters of cyclohexylcyclohexanecarboxylic acid, cyclohexyl esters of cyclohexylcyclohexanecarboxylic acid, cyclohexylphenyl esters of benzoic acid, cyclohexylphenyl esters of cyclohexanecarboxylic acid, cyclohexylphenyl esters of cyclohexylcyclohexanecarboxylic acid, phenylcyclohexanes, cyclohexylbiphenyls, phenylcyclohexylcyclohexanes, cyclohexylcyclohexanes, cyclohexylcyclohexenes, cyclohexylcyclohexylcyclohexenes, 1,4-bis-cyclohexylbenzenes, 4,4′-bis-cyclohexylbiphenyls, phenylpyrimidines, cyclohexylpyrimidines, phenylpyridines, cyclohexylpyridines, phenylpyridazines, cyclohexylpyridazines, phenyldioxanes, cyclohexyldioxanes, phenyl-1,3-dithianes, cyclohexyl-1,3-dithianes, 1,2-diphenylethanes, 1,2-dicyclohexylethanes, 1-phenyl-2-cyclohexylethanes, 1-cyclohexyl-2-(4-phenylcyclohexyl) ethanes, 1-cyclohexyl-2-biphenylethanes, 1-phenyl-2-cyclohexylphenylethanes, halogenated stilbenes, benzyl phenyl ether, tolanes, substituted cinnamic acids, or any combination thereof.

Assignees

Inventors

Classifications

  • C09K19/588Primary

    Heterocyclic compounds · CPC title

  • C09K19/586Primary

    Optically active dopants; chiral dopants · CPC title

  • based on a change of the texture state of a cholesteric liquid crystal · CPC title

  • Filters (polarising elements G02B5/30) · CPC title

  • characterised by optical, electrical or physical properties of the components, in general · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11814563B2 cover?
The disclosure discusses chiral dopants for liquid-crystalline materials. Chiral dopants can be bioreachable compounds, i.e. compounds produced from microbes through fermentation. Chiral dopants can also include bioreachable materials that are further modified by chemical synthetic steps. Chiral dopants as discussed herein can include biomolecules such as glycyrrhetinic acid (1), S-naringenin (…
Who is the assignee on this patent?
Zymergen Inc, Univ Kent State Ohio
What technology area does this patent fall under?
Primary CPC classification C09K19/588. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).